RT @doctorRBC: Drug retention of TNFi vs. secukinumab in AxSpA pts Abs#911 âï¸46% discontinued either treatment âï
Tweet Content
Drug retention of TNFi vs. secukinumab in AxSpA pts
Abs#911
⭐️46% discontinued either treatment
⭐️TNFi with slightly better drug retention
⭐️Age, BASDAI, BMI did not favor any group
⭐️inefficacy - main reason
#ACR21 @RheumNow https://t.co/ynoomYrTvX
Show on Archive Page
On
Display in Search Results
On
PDQ
Off